<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK184570" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK184570/" /><meta name="ncbi_pagename" content="Leukodystrophy Overview - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Leukodystrophy Overview - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Leukodystrophy Overview" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/02/06" /><meta name="citation_author" content="Adeline Vanderver" /><meta name="citation_author" content="Davide Tonduti" /><meta name="citation_author" content="Raphael Schiffmann" /><meta name="citation_author" content="Johanna Schmidt" /><meta name="citation_author" content="Marjo S van der Knaap" /><meta name="citation_pmid" content="24501781" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK184570/" /><meta name="citation_keywords" content="1,4-alpha-glucan-branching enzyme" /><meta name="citation_keywords" content="Aldehyde dehydrogenase family 3 member A2" /><meta name="citation_keywords" content="Arylsulfatase A" /><meta name="citation_keywords" content="Aspartate--tRNA ligase, mitochondrial" /><meta name="citation_keywords" content="Aspartoacylase" /><meta name="citation_keywords" content="ATP-binding cassette sub-family D member 1" /><meta name="citation_keywords" content="Deoxynucleoside triphosphate triphosphohydrolase SAMHD1" /><meta name="citation_keywords" content="DNA-directed RNA polymerase III subunit RPC1" /><meta name="citation_keywords" content="DNA-directed RNA polymerase III subunit RPC2" /><meta name="citation_keywords" content="Double-stranded RNA-specific adenosine deaminase" /><meta name="citation_keywords" content="Formylglycine-generating enzyme" /><meta name="citation_keywords" content="Galactocerebrosidase" /><meta name="citation_keywords" content="Gap junction alpha-1 protein" /><meta name="citation_keywords" content="Gap junction gamma-2 protein" /><meta name="citation_keywords" content="Glial fibrillary acidic protein" /><meta name="citation_keywords" content="Hepatocyte cell adhesion molecule" /><meta name="citation_keywords" content="Hyccin" /><meta name="citation_keywords" content="L-2-hydroxyglutarate dehydrogenase, mitochondrial" /><meta name="citation_keywords" content="Lamin-B1" /><meta name="citation_keywords" content="Macrophage colony-stimulating factor 1 receptor" /><meta name="citation_keywords" content="Membrane protein MLC1" /><meta name="citation_keywords" content="Myelin proteolipid protein" /><meta name="citation_keywords" content="Non-specific lipid-transfer protein" /><meta name="citation_keywords" content="Peroxisomal acyl-coenzyme A oxidase 1" /><meta name="citation_keywords" content="Peroxisomal biogenesis factor 19" /><meta name="citation_keywords" content="Peroxisomal biogenesis factor 3" /><meta name="citation_keywords" content="Peroxisomal membrane protein PEX13" /><meta name="citation_keywords" content="Peroxisomal membrane protein PEX14" /><meta name="citation_keywords" content="Peroxisomal membrane protein PEX16" /><meta name="citation_keywords" content="Peroxisomal multifunctional enzyme type 2" /><meta name="citation_keywords" content="Peroxisomal targeting signal 1 receptor" /><meta name="citation_keywords" content="Peroxisome assembly factor 2" /><meta name="citation_keywords" content="Peroxisome assembly protein 12" /><meta name="citation_keywords" content="Peroxisome assembly protein 26" /><meta name="citation_keywords" content="Peroxisome biogenesis factor 1" /><meta name="citation_keywords" content="Peroxisome biogenesis factor 10" /><meta name="citation_keywords" content="Peroxisome biogenesis factor 2" /><meta name="citation_keywords" content="Probable glutamate--tRNA ligase, mitochondrial" /><meta name="citation_keywords" content="Prosaposin" /><meta name="citation_keywords" content="Ribonuclease H2 subunit A" /><meta name="citation_keywords" content="Ribonuclease H2 subunit B" /><meta name="citation_keywords" content="Ribonuclease H2 subunit C" /><meta name="citation_keywords" content="Ribonuclease T2" /><meta name="citation_keywords" content="Sialin" /><meta name="citation_keywords" content="Sterol 26-hydroxylase, mitochondrial" /><meta name="citation_keywords" content="Three prime repair exonuclease 1" /><meta name="citation_keywords" content="Tissue alpha-L-fucosidase" /><meta name="citation_keywords" content="Transcription factor SOX-10" /><meta name="citation_keywords" content="Translation initiation factor eIF-2B subunit alpha" /><meta name="citation_keywords" content="Translation initiation factor eIF-2B subunit beta" /><meta name="citation_keywords" content="Translation initiation factor eIF-2B subunit delta" /><meta name="citation_keywords" content="Translation initiation factor eIF-2B subunit epsilon" /><meta name="citation_keywords" content="Translation initiation factor eIF-2B subunit gamma" /><meta name="citation_keywords" content="Tubulin beta-4A chain" /><meta name="citation_keywords" content="ABCD1" /><meta name="citation_keywords" content="ACOX1" /><meta name="citation_keywords" content="ADAR" /><meta name="citation_keywords" content="ALDH3A2" /><meta name="citation_keywords" content="ARSA" /><meta name="citation_keywords" content="ASPA" /><meta name="citation_keywords" content="CSF1R" /><meta name="citation_keywords" content="CYP27A1" /><meta name="citation_keywords" content="DARS2" /><meta name="citation_keywords" content="EARS2" /><meta name="citation_keywords" content="EIF2B1" /><meta name="citation_keywords" content="EIF2B2" /><meta name="citation_keywords" content="EIF2B3" /><meta name="citation_keywords" content="EIF2B4" /><meta name="citation_keywords" content="EIF2B5" /><meta name="citation_keywords" content="FAM126A" /><meta name="citation_keywords" content="FUCA1" /><meta name="citation_keywords" content="GALC" /><meta name="citation_keywords" content="GBE1" /><meta name="citation_keywords" content="GFAP" /><meta name="citation_keywords" content="GJA1" /><meta name="citation_keywords" content="GJC2" /><meta name="citation_keywords" content="HEPACAM" /><meta name="citation_keywords" content="HSD17B4" /><meta name="citation_keywords" content="L2HGDH" /><meta name="citation_keywords" content="LMNB1" /><meta name="citation_keywords" content="MLC1" /><meta name="citation_keywords" content="PEX1" /><meta name="citation_keywords" content="PEX10" /><meta name="citation_keywords" content="PEX12" /><meta name="citation_keywords" content="PEX13" /><meta name="citation_keywords" content="PEX14" /><meta name="citation_keywords" content="PEX16" /><meta name="citation_keywords" content="PEX19" /><meta name="citation_keywords" content="PEX2" /><meta name="citation_keywords" content="PEX26" /><meta name="citation_keywords" content="PEX3" /><meta name="citation_keywords" content="PEX5" /><meta name="citation_keywords" content="PEX6" /><meta name="citation_keywords" content="PLP1" /><meta name="citation_keywords" content="POLR3A" /><meta name="citation_keywords" content="POLR3B" /><meta name="citation_keywords" content="PSAP" /><meta name="citation_keywords" content="RNASEH2A" /><meta name="citation_keywords" content="RNASEH2B" /><meta name="citation_keywords" content="RNASEH2C" /><meta name="citation_keywords" content="RNASET2" /><meta name="citation_keywords" content="SAMHD1" /><meta name="citation_keywords" content="SCP2" /><meta name="citation_keywords" content="SLC17A5" /><meta name="citation_keywords" content="SOX10" /><meta name="citation_keywords" content="SUMF1" /><meta name="citation_keywords" content="TREX1" /><meta name="citation_keywords" content="TUBB4A" /><meta name="citation_keywords" content="Leukodystrophy" /><meta name="citation_keywords" content="Overview" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Leukodystrophy Overview" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Adeline Vanderver" /><meta name="DC.Contributor" content="Davide Tonduti" /><meta name="DC.Contributor" content="Raphael Schiffmann" /><meta name="DC.Contributor" content="Johanna Schmidt" /><meta name="DC.Contributor" content="Marjo S van der Knaap" /><meta name="DC.Date" content="2014/02/06" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK184570/" /><meta name="description" content="Leukodystrophies are heritable myelin disorders affecting the white matter of the central nervous system with or without peripheral nervous system myelin involvement. Involvement of the white matter tracts almost universally leads to motor involvement that manifests as hypotonia in early childhood and progresses to spasticity over time. This may lead to variable motor impairment, from mild spastic diplegia to severe spastic quadriplegia that limits purposeful movement. In addition, motor dysfunction is likely to significantly impair vital functions including swallowing, chewing, and (in some cases) respiration. Other findings that vary by disorder include extrapyramidal movement disorders (e.g., dystonia and/or dyskinesias), ataxia, seizures, and delay in cognitive development or change in cognitive function over time." /><meta name="og:title" content="Leukodystrophy Overview" /><meta name="og:type" content="book" /><meta name="og:description" content="Leukodystrophies are heritable myelin disorders affecting the white matter of the central nervous system with or without peripheral nervous system myelin involvement. Involvement of the white matter tracts almost universally leads to motor involvement that manifests as hypotonia in early childhood and progresses to spasticity over time. This may lead to variable motor impairment, from mild spastic diplegia to severe spastic quadriplegia that limits purposeful movement. In addition, motor dysfunction is likely to significantly impair vital functions including swallowing, chewing, and (in some cases) respiration. Other findings that vary by disorder include extrapyramidal movement disorders (e.g., dystonia and/or dyskinesias), ataxia, seizures, and delay in cognitive development or change in cognitive function over time." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK184570/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/leukodys-ov/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK184570/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE89C50AE04057810000000003DB01AF.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK184570_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK184570_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/lns/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/lbsl/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK184570_"><span class="title" itemprop="name">Leukodystrophy Overview</span></h1><p class="contrib-group"><span itemprop="author">Adeline Vanderver</span>, MD, <span itemprop="author">Davide Tonduti</span>, MD, <span itemprop="author">Raphael Schiffmann</span>, MD, <span itemprop="author">Johanna Schmidt</span>, MPH, MGC, CGC, and <span itemprop="author">Marjo S van der Knaap</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK184570_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK184570_ai__"><div class="contrib half_rhythm"><span itemprop="author">Adeline Vanderver</span>, MD<div class="affiliation small">Children's Hospital of Philadelphia<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.pohc.liame@arevrednav" class="oemail">ude.pohc.liame@arevrednav</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Davide Tonduti</span>, MD<div class="affiliation small">Department of Child Neurology and Psychiatry, IRCCS C<br />Mondino Institute of Neurology Foundation<br />Pavia, Italy<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamtoh@udnotedivad" class="oemail">moc.liamtoh@udnotedivad</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Raphael Schiffmann</span>, MD<div class="affiliation small">Institute of Metabolic Disease<br />Baylor Research Institute<br />Dallas, Texas<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.htlaehrolyab@99051p" class="oemail">ude.htlaehrolyab@99051p</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Johanna Schmidt</span>, MPH, MGC, CGC<div class="affiliation small">Department of Neurology &#x00026; Center for Genetic Medicine Research<br />Children's National Medical Center<br />Washington, DC<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.lanoitansnerdlihc@sneweolj" class="oemail">gro.lanoitansnerdlihc@sneweolj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Marjo S van der Knaap</span>, MD, PhD<div class="affiliation small">Department of Child Neurology<br />Vrije Universiteit Medical Center<br />Amsterdam, Netherlands<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ln.cmuv@paankrednav.sm" class="oemail">ln.cmuv@paankrednav.sm</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 6, 2014</span>.</p><p><em>Estimated reading time: 18 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="leukodys-ov.Summary" itemprop="description"><h2 id="_leukodys-ov_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Leukodystrophies are heritable myelin disorders affecting the white matter of the central nervous system with or without peripheral nervous system myelin involvement. Involvement of the white matter tracts almost universally leads to motor involvement that manifests as hypotonia in early childhood and progresses to spasticity over time. This may lead to variable motor impairment, from mild spastic diplegia to severe spastic quadriplegia that limits purposeful movement. In addition, motor dysfunction is likely to significantly impair vital functions including swallowing, chewing, and (in some cases) respiration. Other findings that vary by disorder include extrapyramidal movement disorders (e.g., dystonia and/or dyskinesias), ataxia, seizures, and delay in cognitive development or change in cognitive function over time.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Establishing the specific leukodystrophy present in a given individual usually involves:</p><ul><li class="half_rhythm"><div>Obtaining a medical history and detailed family history</div></li><li class="half_rhythm"><div>Performing a physical examination and neurologic examination</div></li><li class="half_rhythm"><div>Review of brain MRI findings:</div><ul><li class="half_rhythm"><div>T<sub>2</sub>-weighted hyperintensity in the white matter is the MRI finding required for diagnosis of a leukodystrophy.</div></li><li class="half_rhythm"><div>T<sub>1</sub>-weighted signal may be variable: iso- or hyperintense T<sub>1</sub>-weighted signal is consistent with a hypomyelinating leukodystrophy; hypointense T<sub>1</sub>-weighted signal is consistent with a demyelinating leukodystrophy.</div></li></ul></li><li class="half_rhythm"><div>Performing specialized laboratory testing, often including <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (either stepwise single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> targeted to the leukodystrophies).</div></li></ul></div><div><h4 class="inline">Genetic counseling.</h4><p>Leukodystrophies with an identified genetic cause may be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner, an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner, or an <a class="def" href="/books/n/gene/glossary/def-item/x-linked-recessive/">X-linked recessive</a> manner. Genetic counseling regarding risk to family members depends on accurate diagnosis, determination of the <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> in each family, and results of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>. Prenatal testing for pregnancies at increased risk is possible for some types of leukodystrophy if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) in the family are known. Many leukodystrophies are still without an identified genetic cause; once a genetic cause is identified, other inheritance patterns may emerge.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatment is symptomatic and ideally occurs in a multidisciplinary setting by specialists experienced in the care of persons with a leukodystrophy. Pharmacologic agents are used to manage muscle tone and block neuronal signaling to muscle (chemodenervation). Intensive physical therapy is used to improve mobility and function. Pharmacologic treatment of dystonia and dyskinesias may result in significant functional improvement. Treatment of ataxia, seizures, and cognitive issues is provided in the usual manner, depending on the needs of the individual.</p><p><i>Prevention of primary manifestations:</i> In a few leukodystrophies primary disease manifestations can be prevented by hematopoietic stem cell transplantation (HSCT) or bone marrow transplantation (BMT) early in the disease course.</p><p><i>Surveillance:</i> Routine assessment of growth and nutritional status; physical examination and/or serial x-rays of the hips and spine to monitor for orthopedic complications; and routine history regarding signs and symptoms of seizures.</p><p><i>Agents/circumstances to avoid:</i> Mild head injuries and infection as these may exacerbate disease manifestations.</p><p><i>Evaluation of relatives at risk:</i> When primary prevention of a leukodystrophy is possible (e.g., by HSCT or BMT), it is appropriate to offer testing to asymptomatic at-risk relatives who would benefit from early diagnosis and consideration of early treatment.</p></div></div><div id="leukodys-ov.Definition_of_Leukodystrophy"><h2 id="_leukodys-ov_Definition_of_Leukodystrophy_">Definition of Leukodystrophy</h2><p>The term "leukodystrophy," as well as associated terms such as "dysmyelination," "demyelination," and "leukoencephalopathy," is applied to a broad group of disorders.</p><p>In this <i>GeneReview</i>, the following definition is used: Leukodystrophies are heritable myelin disorders affecting the white matter of the central nervous system with or without peripheral nervous system myelin involvement.</p><p>Leukodystrophies share the following findings:</p><ul><li class="half_rhythm"><div>Abnormalities of the glial cell or myelin sheath, such that neuropathology &#x02013; when known &#x02013; is characterized primarily by involvement of oligodendrocytes, astrocytes, and other non-neuronal cell types. Of note, in many leukodystrophies the underlying disease mechanism is unknown.</div></li><li class="half_rhythm"><div>MRI findings (see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F1/?report=objectonly" target="object" rid-figpopup="figleukodysovF1" rid-ob="figobleukodysovF1">Figure 1</a>)</div><ul><li class="half_rhythm"><div>T<sub>2</sub>-weighted hyperintensity in the white matter must be present.</div></li><li class="half_rhythm"><div>T<sub>1</sub>-weighted signal may be variable: iso- or hyperintense T<sub>1</sub>-weighted signal is consistent with a hypomyelinating leukodystrophy; hypointense T<sub>1</sub>-weighted signal is consistent with a demyelinating leukodystrophy.</div></li></ul></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figleukodysovF1" co-legend-rid="figlgndleukodysovF1"><a href="/books/NBK184570/figure/leukodys-ov.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figleukodysovF1" rid-ob="figobleukodysovF1"><img class="small-thumb" src="/books/NBK184570/bin/leukodys-ov-Image001.gif" src-large="/books/NBK184570/bin/leukodys-ov-Image001.jpg" alt="Figure 1. . Hypomyelinating leukodystrophy has T2-weighted hyperintensity (&#x02191;) and T1-weighted iso- (&#x02192;) or hyperintensity (&#x02191;) of affected white matter." /></a><div class="icnblk_cntnt" id="figlgndleukodysovF1"><h4 id="leukodys-ov.F1"><a href="/books/NBK184570/figure/leukodys-ov.F1/?report=objectonly" target="object" rid-ob="figobleukodysovF1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Hypomyelinating leukodystrophy has T<sub>2</sub>-weighted hyperintensity (&#x02191;) and T<sub>1</sub>-weighted iso- (&#x02192;) or hyperintensity (&#x02191;) of affected white matter. Demyelinating leukodystrophy has T<sub>2</sub>-weighted hyperintensity (&#x02191;) and T<sub>1</sub>-weighted <a href="/books/NBK184570/figure/leukodys-ov.F1/?report=objectonly" target="object" rid-ob="figobleukodysovF1">(more...)</a></p></div></div></div><div id="leukodys-ov.Clinical_Manifestations_of_L"><h2 id="_leukodys-ov_Clinical_Manifestations_of_L_">Clinical Manifestations of Leukodystrophies</h2><p>A number of leukodystrophies that meet the definition used in this <i>GeneReview</i> are listed in <a class="figpopup" href="/books/NBK184570/table/leukodys-ov.T.leukodystrophies_meeting_s/?report=objectonly" target="object" rid-figpopup="figleukodysovTleukodystrophiesmeetings" rid-ob="figobleukodysovTleukodystrophiesmeetings">Table 1</a>.</p><p>Involvement of the white matter tracts almost universally leads to motor involvement that manifests as hypotonia in early childhood and progresses to spasticity over time. This may lead to variable motor impairment, from mild spastic diplegia to severe spastic quadriplegia that limits purposeful movement. In addition, motor dysfunction is likely to significantly impair vital functions including swallowing, chewing, and (in some cases) respiration. Spasticity may result in orthopedic complications such as scoliosis and large joint luxation.</p><p>Significant pyramidal dysfunction (i.e., spasticity) may sometimes mask or overshadow the presence of extrapyramidal movement disorders such as dystonia and/or dyskinesias. For example, in <a href="/books/n/gene/thctd/">MCT8-specific thyroid hormone cell transporter deficiency</a> dystonia is a prominent finding.</p><p>Ataxia is a predominant finding in some leukodystrophies and can be disabling; for example, <a href="/books/n/gene/cach/">childhood ataxia with central nervous system hypomyelination/vanishing white matter</a> (CACH/VWM) and <a href="/books/n/gene/pol3-leuk/">hypomyelination with hypogonadotropic hypogonadism and hypodontia</a> (4H syndrome).</p><p>Seizures are an often late manifestation of leukodystrophies, with the exception of rare leukodystrophies (e.g., <a href="/books/n/gene/alexander/">Alexander disease</a>) in which they are often a presenting feature.</p><p>Delay in cognitive development or change in cognitive function over time, while far less pronounced than motor dysfunction, can be common in the child or adult with leukodystrophy. Because progressive loss of cognitive function is slow in the majority of leukodystrophies, dementia is not an early feature.</p></div><div id="leukodys-ov.Prevalence_of_Leukodystrophi"><h2 id="_leukodys-ov_Prevalence_of_Leukodystrophi_">Prevalence of Leukodystrophies</h2><p>Epidemiologic data on the frequency of leukodystrophies overall are limited [<a class="bk_pop" href="#leukodys-ov.REF.heim.1997.475">Heim et al 1997</a>, <a class="bk_pop" href="#leukodys-ov.REF.bonkowsky.2010.718">Bonkowsky et al 2010</a>]. Furthermore, it is difficult to infer from these studies with any certainty the relative frequency of specific leukodystrophies.</p><p>Better information on prevalence is available for leukodystrophies that are seen regularly in specialized clinics and in general child neurology practices; these include <a href="/books/n/gene/alexander/">Alexander disease</a> [<a class="bk_pop" href="#leukodys-ov.REF.van_der_knaap.1999.121">van der Knaap et al 1999</a>], <a href="/books/n/gene/x-ald/">X-linked adrenoleukodystrophy</a> [<a class="bk_pop" href="#leukodys-ov.REF.bezman.2001.512">Bezman et al 2001</a>], and <a href="/books/n/gene/mld/">metachromatic leukodystrophy</a>.</p><p>As disorders such as certain adult-onset-only leukodystrophies and hypomyelinating leukodystrophies become better defined, the heterogeneity of the inherited white matter disorders is increasingly recognized.</p><p>It is important to note that in approximately 50% of individuals with a white matter disorder the specific etiology is unknown because of the heterogeneity and complexity of these disorders [<a class="bk_pop" href="#leukodys-ov.REF.schiffmann.2009.750">Schiffmann &#x00026; van der Knaap 2009</a>].</p></div><div id="leukodys-ov.Differential_Diagnosis_of_Le"><h2 id="_leukodys-ov_Differential_Diagnosis_of_Le_">Differential Diagnosis of Leukodystrophies</h2><p><b>Hereditable disorders with significant white matter involvement</b> that are not leukodystrophies are listed in <a href="/books/NBK184570/bin/leukodys-ov-Table2.pdf">Table 2</a> (pdf); they include the following:</p><ul><li class="half_rhythm"><div><b>Inherited vasculopathies</b> that can result in white matter signal abnormalities, including inherited abnormalities of the vessel wall, such as <a href="/books/n/gene/cadasil/">CADASIL</a> and <a href="/books/n/gene/col4a1-dis/"><i>COL4A1</i></a> and <i>COL4A2-</i>related disorders, which can give rise to multifocal white matter abnormalities. In end-stage disease, confluent signal abnormalities in the periventricular and deep white matter may be seen, typically with multifocal abnormalities in central gray matter structures and brain stem. Because these are not primary glial cell disorders, they are not considered to be leukodystrophies.</div></li><li class="half_rhythm"><div><b>CNS diseases</b>
<b>with primary involvement of neurons in the cerebral cortex or other gray matter structures</b> (in which brain MRI also reveals significant white matter abnormalities). Typical findings are significant encephalopathy and seizures.</div><ul><li class="half_rhythm"><div>The infantile variants of disorders like <a href="/books/n/gene/gm1-ganglio/">GM1 gangliosidosis</a>, <a href="/books/n/gene/tay-sachs/">GM2 gangliosidosis</a>, and neuronal ceroid-lipofuscinosis may have significant white matter abnormalities because the disease, which is primarily neuronal, also disrupts the normal process of myelination. Later-onset variants of these disorders eventually affect the cerebral white matter; mild signal abnormalities are related to Wallerian degeneration with loss of axons and myelin.</div></li><li class="half_rhythm"><div>In other disorders, such as <a href="/books/n/gene/thctd/">MCT8-specific thyroid hormone cell transporter deficiency</a>, myelination can be extremely delayed but progress over time to become almost complete.</div></li></ul></li><li class="half_rhythm"><div><b>Inborn errors of metabolism</b> with significant secondary white matter abnormalities, such as organic acidemias, disorders of amino acid metabolism, and many others. See <a href="/books/NBK184570/bin/leukodys-ov-Table2.pdf">Table 2</a> (pdf).</div></li><li class="half_rhythm"><div><b>Disorders that affect both white and gray matter.</b> Examples in which both white matter injury and gray matter lesions are observed include mitochondrial disorders such as <a href="/books/n/gene/melas/">MELAS</a> (<i>m</i>itochondrial <i>e</i>ncephalopathy with <i>l</i>actic <i>a</i>cidosis and <i>s</i>eizures), <a href="/books/n/gene/alpers/"><i>POLG</i>-related disorders</a>, and <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> hemophagocytic lymphohistiocytosis.</div></li></ul><p><b>Other disorders with significant white matter</b>
<b>involvement</b> include the following:</p><ul><li class="half_rhythm"><div><b>Acquired CNS myelin disorders</b> that result in demyelination, such as multiple sclerosis and those of <b>infectious, post-infectious, and autoimmune</b> etiology. Although not heritable in a Mendelian fashion, some of these disorders may have <a class="def" href="/books/n/gene/glossary/def-item/multifactorial/">multifactorial</a> etiologies that include a genetic predisposition.</div></li><li class="half_rhythm"><div>Disorders such as acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica typically differ from heritable white matter disorders by their abrupt onset and multiphasic presentations. Brain MRI abnormalities are also more likely to be multifocal and patchy [<a class="bk_pop" href="#leukodys-ov.REF.schiffmann.2009.750">Schiffmann &#x00026; van der Knaap 2009</a>], with variation or even improvement over time and with treatment.</div></li><li class="half_rhythm"><div><b>Toxic injuries</b> of the myelin, such as those seen in heroin abuse or methotrexate-related toxicity</div></li><li class="half_rhythm"><div><b>Central nervous system injury,</b> particularly in the perinatal period, which can result in significant white matter signal abnormalities that are typically irregular, and may result in loss of white matter volume</div></li><li class="half_rhythm"><div>Non-genetic vascular insults</div></li></ul></div><div id="leukodys-ov.Evaluation_Strategy_for_an_I"><h2 id="_leukodys-ov_Evaluation_Strategy_for_an_I_">Evaluation Strategy for an Individual with a Leukodystrophy</h2><p>Once a leukodystrophy is considered in an individual, the following approach can be used to determine the specific leukodystrophy to aid in discussions of prognosis and <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a>.</p><p>Establishing the specific leukodystrophy (<a class="figpopup" href="/books/NBK184570/table/leukodys-ov.T.leukodystrophies_meeting_s/?report=objectonly" target="object" rid-figpopup="figleukodysovTleukodystrophiesmeetings" rid-ob="figobleukodysovTleukodystrophiesmeetings">Table 1</a>) present in a given individual usually involves obtaining a medical history and detailed family history; performing a physical examination and neurologic examination; review of brain MRI findings; and specialized laboratory testing, often including <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p><p>Note: Adherence to the diagnostic approach discussed in this section notwithstanding, a specific diagnosis cannot be established in a clinical (i.e., not research) setting in a significant number of individuals with a leukodystrophy [<a class="bk_pop" href="#leukodys-ov.REF.van_der_knaap.1999.121">van der Knaap et al 1999</a>, <a class="bk_pop" href="#leukodys-ov.REF.schiffmann.2009.750">Schiffmann &#x00026; van der Knaap 2009</a>].</p><div id="leukodys-ov.Medical_History"><h3>Medical History</h3><p>A history of certain clinical features may be helpful in identifying a specific leukodystrophy; however, in the majority of cases, only nonspecific loss of function (primarily motor) occurs and medical history alone does not provide insight into a specific diagnosis.</p><p>In the hypomyelinating leukodystrophies helpful diagnostic clues may, for example, be the following:</p><ul><li class="half_rhythm"><div>Congenital cataract: <a href="/books/n/gene/hypo-mcc/">hypomyelination and congenital cataract</a> (HCC)</div></li><li class="half_rhythm"><div>Hypodontia and/or hypogonadotropic hypogonadism: <a href="/books/n/gene/pol3-leuk/"><i>POLR3</i>-related leukodystrophy</a></div></li><li class="half_rhythm"><div>Severe seizures: <a href="/books/n/gene/issd/">sialic acid storage disorders</a></div></li></ul><p>In the demyelinating leukodystrophies helpful diagnostic clues may, for example, be the following:</p><ul><li class="half_rhythm"><div>Recurrent vomiting: <a href="/books/n/gene/alexander/">Alexander disease</a></div></li><li class="half_rhythm"><div>Adrenal dysfunction: <a href="/books/n/gene/x-ald/">X-linked adrenoleukodystrophy</a> (X-ALD)</div></li><li class="half_rhythm"><div>Early-onset autonomic dysfunction: <a href="/books/n/gene/lad-ad/">AD adult-onset leukodystrophy</a> (ADLD)</div></li><li class="half_rhythm"><div>Chronic cerebrospinal fluid lymphocytosis or (more often) recurrent "aseptic meningitis": <a href="/books/n/gene/ags/">Aicardi-Gouti&#x000e8;res syndrome</a></div></li><li class="half_rhythm"><div>Abrupt loss of function after a fever or fall: <a href="/books/n/gene/cach/">childhood ataxia with central nervous system hypomyelination/vanishing white matter</a> (and possibly other leukodystrophies)</div></li></ul></div><div id="leukodys-ov.Family_History"><h3>Family History</h3><p>A detailed three-generation family history should be compiled, focusing on individuals with hypotonia, spasticity, dystonia, seizures, ataxia, and/or delay in cognitive development or change in cognitive function over time.</p><ul><li class="half_rhythm"><div>Because most leukodystrophies are <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>, special attention to parental <a href="/books/n/gene/glossary/def-item/consanguinity/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri"><u>consanguinity</u></a> and medical problems in sibs is warranted.</div></li><li class="half_rhythm"><div>Evaluation of relatives and/or review of their medical records may be needed.</div></li></ul></div><div id="leukodys-ov.Physical_Examination_and_Neu"><h3>Physical Examination and Neurologic Examination</h3><p>In most instances physical findings do not suggest a specific diagnosis; however, certain findings may direct the reader to further explore specific underlying etiologies:</p><ul><li class="half_rhythm"><div>Macrocephaly; see <a href="/books/NBK184570/bin/leukodys-ov-Tables5-6.pdf">Table 6</a> (pdf)</div></li><li class="half_rhythm"><div>Abnormal dentition: <a href="/books/n/gene/pol3-leuk/"><i>POLR3</i>-related leukodystrophy</a> or oculodentodigital dysplasia (ODDD)</div></li><li class="half_rhythm"><div>Palatal myoclonus in adults: <a href="/books/n/gene/alexander/">Alexander disease</a></div></li><li class="half_rhythm"><div>Xanthomas: <a href="/books/n/gene/ctx/">cerebrotendinous xanthomatosis</a> (CTX)</div></li><li class="half_rhythm"><div>Abnormalities of skin pigmentation: <a href="/books/n/gene/x-ald/">X-linked adrenoleukodystrophy</a> (X-ALD)</div></li><li class="half_rhythm"><div>Ichthyosis: Sj&#x000f6;gren-Larsson syndrome</div></li><li class="half_rhythm"><div>Vascular retinal abnormalities: cerebroretinal microangiopathy w/calcifications &#x00026; cysts (CRMCC)</div></li><li class="half_rhythm"><div>Cherry red spot on retinal examination: disorders such as <a href="/books/n/gene/gm1-ganglio/">GM1</a> and <a href="/books/n/gene/tay-sachs/">GM2 gangliosidosis</a></div></li></ul></div><div id="leukodys-ov.Brain_MRI_Findings"><h3>Brain MRI Findings</h3><div id="leukodys-ov.Step_1"><h4>Step 1</h4><p>Establish whether the pattern of brain MRI abnormalities is consistent with a hypomyelinating leukodystrophy or a demyelinating leukodystrophy (<a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F1/?report=objectonly" target="object" rid-figpopup="figleukodysovF1" rid-ob="figobleukodysovF1">Figure 1</a>) [<a class="bk_pop" href="#leukodys-ov.REF.van_der_knaap.1999.121">van der Knaap et al 1999</a>, <a class="bk_pop" href="#leukodys-ov.REF.van_der_knaap.2005">van der Knaap &#x00026; Valk 2005</a>, <a class="bk_pop" href="#leukodys-ov.REF.schiffmann.2009.750">Schiffmann &#x00026; van der Knaap 2009</a>].</p></div><div id="leukodys-ov.Step_2"><h4>Step 2</h4><p>Within the hypomyelinating and demyelinating leukodystrophies, determine if patterns of involvement suggest specific diagnoses.</p><p><b>Hypomyelinating leukodystrophy.</b> Note specific patterns on neuroimaging that include the following (<a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F2/?report=objectonly" target="object" rid-figpopup="figleukodysovF2" rid-ob="figobleukodysovF2">Figure 2</a>):</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figleukodysovF2" co-legend-rid="figlgndleukodysovF2"><a href="/books/NBK184570/figure/leukodys-ov.F2/?report=objectonly" target="object" title="Figure 2. " class="img_link icnblk_img figpopup" rid-figpopup="figleukodysovF2" rid-ob="figobleukodysovF2"><img class="small-thumb" src="/books/NBK184570/bin/leukodys-ov-Image002.gif" src-large="/books/NBK184570/bin/leukodys-ov-Image002.jpg" alt="Figure 2. " /></a><div class="icnblk_cntnt" id="figlgndleukodysovF2"><h4 id="leukodys-ov.F2"><a href="/books/NBK184570/figure/leukodys-ov.F2/?report=objectonly" target="object" rid-ob="figobleukodysovF2">Figure 2. </a></h4><p class="float-caption no_bottom_margin">Hypomyelinating leukodystrophy &#x02013; patterns on MRI A&#x02192;B. Improvement of myelination over time in MCT8-specific thyroid hormone cell transporter deficiency seen in a male with documented <i>SLC16A2</i> (<i>MCT8</i>) pathogenic variants at age two years <a href="/books/NBK184570/figure/leukodys-ov.F2/?report=objectonly" target="object" rid-ob="figobleukodysovF2">(more...)</a></p></div></div><ul><li class="half_rhythm"><div>Improvement of myelination over time (e.g., as seen in <a href="/books/n/gene/thctd/">MCT8-specific thyroid hormone cell transporter deficiency</a>; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F2/?report=objectonly" target="object" rid-figpopup="figleukodysovF2" rid-ob="figobleukodysovF2">Figure 2A&#x02192;B</a>)</div></li><li class="half_rhythm"><div>Severe atrophy of cortical gray matter (variably seen in primary neuronal disorders as well as a limited number of classic leukodystrophies; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F2/?report=objectonly" target="object" rid-figpopup="figleukodysovF2" rid-ob="figobleukodysovF2">Figure 2C</a>)</div></li><li class="half_rhythm"><div>Persistent hypomyelination without atrophy of cortical gray matter (e.g., in <a href="/books/n/gene/pmd/">Pelizaeus-Merzbacher disease</a>; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F2/?report=objectonly" target="object" rid-figpopup="figleukodysovF2" rid-ob="figobleukodysovF2">Figure 2D</a>)</div></li><li class="half_rhythm"><div>Cerebellar atrophy (e.g., in <a href="/books/n/gene/pol3-leuk/"><i>POLR3</i>-related leukodystrophy</a> [4H syndrome]; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F2/?report=objectonly" target="object" rid-figpopup="figleukodysovF2" rid-ob="figobleukodysovF2">Figure 2E</a>)</div></li><li class="half_rhythm"><div>Basal ganglia involvement (e.g., in HABC syndrome; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F2/?report=objectonly" target="object" rid-figpopup="figleukodysovF2" rid-ob="figobleukodysovF2">Figure 2F</a>)</div></li></ul><p><b>Demyelinating leukodystrophy</b></p><ul><li class="half_rhythm"><div>Identify the region in which white matter abnormalities predominate.</div></li><li class="half_rhythm"><div>Distinguish confluent from multifocal lesions (<a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F3/?report=objectonly" target="object" rid-figpopup="figleukodysovF3" rid-ob="figobleukodysovF3">Figure 3</a>):</div><ul><li class="half_rhythm"><div>Confluent white matter lesions are extensive white matter abnormalities in significant portions of the brain, often affecting specific regions or tracts, although not necessarily perfectly symmetrically.</div></li><li class="half_rhythm"><div>Multifocal white matter lesions are more discrete, often asymmetric and involving a limited area. Multifocal abnormalities have a specific differential diagnosis.</div></li></ul></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figleukodysovF3" co-legend-rid="figlgndleukodysovF3"><a href="/books/NBK184570/figure/leukodys-ov.F3/?report=objectonly" target="object" title="Figure 3. " class="img_link icnblk_img figpopup" rid-figpopup="figleukodysovF3" rid-ob="figobleukodysovF3"><img class="small-thumb" src="/books/NBK184570/bin/leukodys-ov-Image003.gif" src-large="/books/NBK184570/bin/leukodys-ov-Image003.jpg" alt="Figure 3. . Confluent white matter lesions are extensive white matter abnormalities in significant portions of the brain, often affecting specific regions or tracts, although not necessarily perfectly symmetrically." /></a><div class="icnblk_cntnt" id="figlgndleukodysovF3"><h4 id="leukodys-ov.F3"><a href="/books/NBK184570/figure/leukodys-ov.F3/?report=objectonly" target="object" rid-ob="figobleukodysovF3">Figure 3. </a></h4><p class="float-caption no_bottom_margin">Confluent white matter lesions are extensive white matter abnormalities in significant portions of the brain, often affecting specific regions or tracts, although not necessarily perfectly symmetrically. Multifocal white matter lesions are more discrete, <a href="/books/NBK184570/figure/leukodys-ov.F3/?report=objectonly" target="object" rid-ob="figobleukodysovF3">(more...)</a></p></div></div><p>Specific patterns on neuroimaging in confluent disorders include (<a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F4/?report=objectonly" target="object" rid-figpopup="figleukodysovF4" rid-ob="figobleukodysovF4">Figure 4</a>):</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figleukodysovF4" co-legend-rid="figlgndleukodysovF4"><a href="/books/NBK184570/figure/leukodys-ov.F4/?report=objectonly" target="object" title="Figure 4. " class="img_link icnblk_img figpopup" rid-figpopup="figleukodysovF4" rid-ob="figobleukodysovF4"><img class="small-thumb" src="/books/NBK184570/bin/leukodys-ov-Image004.gif" src-large="/books/NBK184570/bin/leukodys-ov-Image004.jpg" alt="Figure 4. " /></a><div class="icnblk_cntnt" id="figlgndleukodysovF4"><h4 id="leukodys-ov.F4"><a href="/books/NBK184570/figure/leukodys-ov.F4/?report=objectonly" target="object" rid-ob="figobleukodysovF4">Figure 4. </a></h4><p class="float-caption no_bottom_margin">Demyelinating leukodystrophy &#x02013; patterns on MRI A. Diffuse cerebral involvement in an individual with megalencephalic leukodystrophy with subcortical cysts</p></div></div><ul><li class="half_rhythm"><div>Diffuse cerebral involvement (e.g., as seen in <a href="/books/n/gene/mlc/">megalencephalic leukodystrophy with subcortical cysts</a>; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F4/?report=objectonly" target="object" rid-figpopup="figleukodysovF4" rid-ob="figobleukodysovF4">Figure 4A</a>)</div></li><li class="half_rhythm"><div>Frontal involvement (e.g., in <a href="/books/n/gene/alexander/">Alexander disease</a>; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F4/?report=objectonly" target="object" rid-figpopup="figleukodysovF4" rid-ob="figobleukodysovF4">Figure 4B</a>)</div></li><li class="half_rhythm"><div>Parieto-occipital involvement (e.g. in <a href="/books/n/gene/x-ald/">X-linked adrenoleukodystrophy</a>; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F4/?report=objectonly" target="object" rid-figpopup="figleukodysovF4" rid-ob="figobleukodysovF4">Figure 4C</a>)</div></li><li class="half_rhythm"><div>Temporal involvement (e.g., in <a href="/books/n/gene/ags/">Aicardi-Gouti&#x000e8;res syndrome</a>; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F4/?report=objectonly" target="object" rid-figpopup="figleukodysovF4" rid-ob="figobleukodysovF4">Figure 4D</a>)</div></li><li class="half_rhythm"><div>Subcortical involvement (e.g., in <a href="/books/n/gene/kss/">Kearns-Sayre syndrome</a>; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F4/?report=objectonly" target="object" rid-figpopup="figleukodysovF4" rid-ob="figobleukodysovF4">Figure 4E</a>)</div></li><li class="half_rhythm"><div>Periventricular involvement (e.g., in <a href="/books/n/gene/mld/">metachromatic leukodystrophy</a>; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F4/?report=objectonly" target="object" rid-figpopup="figleukodysovF4" rid-ob="figobleukodysovF4">Figure 4F</a>)</div></li><li class="half_rhythm"><div>Brain stem involvement (e.g., in <a href="/books/n/gene/apbd/">adult polyglucosan body disease</a> with heterogeneous involvement of the brain stem; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F4/?report=objectonly" target="object" rid-figpopup="figleukodysovF4" rid-ob="figobleukodysovF4">Figure 4G</a>)</div></li><li class="half_rhythm"><div>Cerebellar/cerebellar peduncle involvement (e.g., in <a href="/books/n/gene/lad-ad/">AD adult-onset leukodystrophy</a> (ADLD) with involvement of the middle cerebellar peduncles; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F4/?report=objectonly" target="object" rid-figpopup="figleukodysovF4" rid-ob="figobleukodysovF4">Figure 4H</a>)</div></li><li class="half_rhythm"><div>Large, asymmetric lesions (e.g., in <a href="/books/n/gene/hdls/">hereditary diffuse leukoencephalopathy with spheroids</a> [HDLS]; <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F4/?report=objectonly" target="object" rid-figpopup="figleukodysovF4" rid-ob="figobleukodysovF4">Figure 4I</a>)</div></li></ul><p><b>Diagnostic algorithm.</b> For algorithms based on MRI findings, see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F5/?report=objectonly" target="object" rid-figpopup="figleukodysovF5" rid-ob="figobleukodysovF5">Figure 5</a> (demyelinating and other conditions) and <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F6/?report=objectonly" target="object" rid-figpopup="figleukodysovF6" rid-ob="figobleukodysovF6">Figure 6</a> (hypomyelinating conditions) [<a class="bk_pop" href="#leukodys-ov.REF.schiffmann.2009.750">Schiffmann &#x00026; van der Knaap 2009</a>].</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figleukodysovF5" co-legend-rid="figlgndleukodysovF5"><a href="/books/NBK184570/figure/leukodys-ov.F5/?report=objectonly" target="object" title="Figure 5. " class="img_link icnblk_img figpopup" rid-figpopup="figleukodysovF5" rid-ob="figobleukodysovF5"><img class="small-thumb" src="/books/NBK184570/bin/leukodys-ov-Image005.gif" src-large="/books/NBK184570/bin/leukodys-ov-Image005.jpg" alt="Figure 5. " /></a><div class="icnblk_cntnt" id="figlgndleukodysovF5"><h4 id="leukodys-ov.F5"><a href="/books/NBK184570/figure/leukodys-ov.F5/?report=objectonly" target="object" rid-ob="figobleukodysovF5">Figure 5. </a></h4><p class="float-caption no_bottom_margin">Algorithm Part 1: Demyelinating and other conditions Adapted from Schiffmann &#x00026; van der Knaap [2009]</p></div></div><div class="iconblock whole_rhythm clearfix ten_col fig" id="figleukodysovF6" co-legend-rid="figlgndleukodysovF6"><a href="/books/NBK184570/figure/leukodys-ov.F6/?report=objectonly" target="object" title="Figure 6. " class="img_link icnblk_img figpopup" rid-figpopup="figleukodysovF6" rid-ob="figobleukodysovF6"><img class="small-thumb" src="/books/NBK184570/bin/leukodys-ov-Image006.gif" src-large="/books/NBK184570/bin/leukodys-ov-Image006.jpg" alt="Figure 6. " /></a><div class="icnblk_cntnt" id="figlgndleukodysovF6"><h4 id="leukodys-ov.F6"><a href="/books/NBK184570/figure/leukodys-ov.F6/?report=objectonly" target="object" rid-ob="figobleukodysovF6">Figure 6. </a></h4><p class="float-caption no_bottom_margin">Algorithm Part 2: Hypomyelinating conditions Adapted from Schiffmann &#x00026; van der Knaap [2009]</p></div></div></div><div id="leukodys-ov.Step_3"><h4>Step 3</h4><p>Look for the following associated features which, in addition to the pattern of findings on brain MRI, can assist in recognition of a specific leukodystrophy:</p><ul><li class="half_rhythm"><div>White matter rarefaction and cysts (<a href="/books/NBK184570/bin/leukodys-ov-Table3.pdf">Table 3</a>) seen on FLAIR imaging (e.g., in vanishing white matter disease: <a href="/books/n/gene/cach/">childhood ataxia with central nervous system hypomyelination/vanishing white matter</a>; <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F7/?report=objectonly" target="object" rid-figpopup="figleukodysovF7" rid-ob="figobleukodysovF7">Figure 7A</a>)</div></li><li class="half_rhythm"><div>Calcium deposits and hemosiderin deposits (<a href="/books/NBK184570/bin/leukodys-ov-Table4.pdf">Table 4</a>) visible on CT, and not easily distinguishable on MRI (e.g., in <a href="/books/n/gene/ags/">Aicardi-Gouti&#x000e8;res syndrome</a>; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F7/?report=objectonly" target="object" rid-figpopup="figleukodysovF7" rid-ob="figobleukodysovF7">Figure 7B</a>)</div></li><li class="half_rhythm"><div>Contrast enhancement (<a href="/books/NBK184570/bin/leukodys-ov-Tables5-6.pdf">Table 5</a>) on T<sub>1</sub>-weighted imaging within the abnormal white matter (e.g., in <a href="/books/n/gene/x-ald/">X-linked adrenoleukodystrophy</a>; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F7/?report=objectonly" target="object" rid-figpopup="figleukodysovF7" rid-ob="figobleukodysovF7">Figure 7C</a>)</div></li><li class="half_rhythm"><div>Leukoencephalopathy with macrocephaly(<a href="/books/NBK184570/bin/leukodys-ov-Tables5-6.pdf">Table 6</a>)</div></li><li class="half_rhythm"><div>Cortical gray matter lesions (<a href="/books/NBK184570/bin/leukodys-ov-Table7.pdf">Table 7</a>) (e.g., in <a href="/books/n/gene/alpers/"><i>POLG</i>-related disorders</a>; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F7/?report=objectonly" target="object" rid-figpopup="figleukodysovF7" rid-ob="figobleukodysovF7">Figure 7D</a>)</div></li><li class="half_rhythm"><div>Cerebellar abnormalities (<a href="/books/NBK184570/bin/leukodys-ov-Table8.pdf">Table 8</a>) seen in the dentate nucleus (e.g., in L-2-hydroxyglutaric aciduria; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F7/?report=objectonly" target="object" rid-figpopup="figleukodysovF7" rid-ob="figobleukodysovF7">Figure 7E</a>)</div></li><li class="half_rhythm"><div>Thinning of the corpus callosum (<a href="/books/NBK184570/bin/leukodys-ov-Table9.pdf">Table 9</a>), in particular, of the genu (e.g., in <a href="/books/n/gene/spg11/">hereditary spastic paraplegia 11</a>; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F7/?report=objectonly" target="object" rid-figpopup="figleukodysovF7" rid-ob="figobleukodysovF7">Figure 7F</a>)</div></li><li class="half_rhythm"><div>Non-calcifying basal ganglia lesions (<a href="/books/NBK184570/bin/leukodys-ov-Table10.pdf">Table 10</a>) (e.g., in <a href="/books/n/gene/alexander/">Alexander disease</a>; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F7/?report=objectonly" target="object" rid-figpopup="figleukodysovF7" rid-ob="figobleukodysovF7">Figure 7G</a>, signal abnormality of the basal ganglia and frontal white matter)</div></li><li class="half_rhythm"><div>Brain stem involvement (<a href="/books/NBK184570/bin/leukodys-ov-Table11.pdf">Table 11</a>) (e.g., in <a href="/books/n/gene/lad-ad/">AD adult-onset leukodystrophy</a> (ADLD); see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F7/?report=objectonly" target="object" rid-figpopup="figleukodysovF7" rid-ob="figobleukodysovF7">Figure 7H</a>)</div></li><li class="half_rhythm"><div>Spinal cord involvement (<a href="/books/NBK184570/bin/leukodys-ov-Table12.pdf">Table 12</a>) (seen in many disorders, including <a href="/books/n/gene/lbsl/">LBSL</a>; see <a class="figpopup" href="/books/NBK184570/figure/leukodys-ov.F7/?report=objectonly" target="object" rid-figpopup="figleukodysovF7" rid-ob="figobleukodysovF7">Figure 7I</a>, an example of involvement of tracts within the spinal cord)</div></li></ul><div class="iconblock whole_rhythm clearfix ten_col fig" id="figleukodysovF7" co-legend-rid="figlgndleukodysovF7"><a href="/books/NBK184570/figure/leukodys-ov.F7/?report=objectonly" target="object" title="Figure 7. " class="img_link icnblk_img figpopup" rid-figpopup="figleukodysovF7" rid-ob="figobleukodysovF7"><img class="small-thumb" src="/books/NBK184570/bin/leukodys-ov-Image007.gif" src-large="/books/NBK184570/bin/leukodys-ov-Image007.jpg" alt="Figure 7. " /></a><div class="icnblk_cntnt" id="figlgndleukodysovF7"><h4 id="leukodys-ov.F7"><a href="/books/NBK184570/figure/leukodys-ov.F7/?report=objectonly" target="object" rid-ob="figobleukodysovF7">Figure 7. </a></h4><p class="float-caption no_bottom_margin">Features associated with specific leukodystrophies A. White matter rarefaction and cysts on FLAIR imaging in vanishing white matter disease; arrow indicates cystic rarefaction within abnormal white matter.</p></div></div></div></div><div id="leukodys-ov.Specialized_Laboratory_Testi"><h3>Specialized Laboratory Testing (Including Molecular Genetic Testing)</h3><p>If the findings on brain MRI are consistent with a specific leukodystrophy, consider biochemical or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for that disorder (<a class="figpopup" href="/books/NBK184570/table/leukodys-ov.T.leukodystrophies_meeting_s/?report=objectonly" target="object" rid-figpopup="figleukodysovTleukodystrophiesmeetings" rid-ob="figobleukodysovTleukodystrophiesmeetings">Table 1</a>). Note: Molecular genetic testing may be performed either as single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing in a stepwise fashion based on the information gained during the evaluation or, if available, as a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p><div id="leukodys-ov.T.leukodystrophies_meeting_s" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Leukodystrophies Meeting Strict Diagnostic Criteria</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK184570/table/leukodys-ov.T.leukodystrophies_meeting_s/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__leukodys-ov.T.leukodystrophies_meeting_s_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Name of Disorder</th><th id="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mode of Inheritance</th><th id="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Biochemical Testing / Other</th></tr></thead><tbody><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">18q <a class="def" href="/books/n/gene/glossary/def-item/deletion-syndrome/">deletion syndrome</a></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Most often <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>; may be inherited</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Chromosome analysis for 18q microdeletion involving <i>MBP</i></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/apbd/">Adult polyglucosan body disease</a> (APBD)</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GBE1</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Histopathologic examination of muscle, nerve, axillary skin: pathologic polyglucosan accumulation</td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ags/">Aicardi-Gouti&#x000e8;res syndrome</a> (AGS)</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Usually AR; may be AD</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TREX1</i><br /><i>RNASEH2A</i><br /><i>RNASEH2B</i><br /><i>RNASEH2C</i><br /><i>SAMHD1</i><br /><i>ADAR</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">CSF analysis: lymphocytosis, &#x02191;&#x000a0;interferon-&#x003b1;, &#x02191;&#x000a0;pterins</td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/alexander/">Alexander disease</a></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GFAP</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/lad-ad/">AD adult-onset leukodystrophy</a> (ADLD)</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LMNB1</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cerebroretinal microangiopathy w/calcifications &#x00026; cysts (CRMCC)&#x000a0;<sup>2</sup></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Likely AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical &#x00026; neuroradiologic features</td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/canavan/">Canavan disease</a></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ASPA</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In urine, plasma, CSF, &#x00026; amniotic fluid: &#x02191;&#x000a0;N-acetylaspartic acid in urine;<br />In skin fibroblasts: deficient aspartoacylase enzyme activity</td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/ctx/">Cerebrotendinous xanthomatosis</a> (CTX)</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CYP27A1</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In plasma &#x00026; CSF: &#x02191;&#x000a0;cholestanol concentration, &#x02193;&#x000a0;chenodeoxycholic acid;<br />In bile, urine, plasma: &#x02191;&#x000a0;concentration bile alcohols &#x00026; glyconjugates;<br />In fibroblasts, liver, leukocytes: &#x02193;&#x000a0;sterol 27-hydroxylase activity</td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/cach/">Childhood ataxia w/CNS hypomyelination / vanishing white matter</a> (CACH/VWM)</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EIF2B1-5</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/issd/">Free sialic acid storage disorders</a>&#x000a0;<sup>3</sup></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SLC17A5</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In urine, fibroblast, lysosomes: &#x02191;&#x000a0;free sialic acid</td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fucosidosis</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FUCA1</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">On urinary oligosaccharide assay: &#x02191;&#x000a0;fucose-containing glycoconjugates;<br />In leukocytes or fibroblasts: deficient &#x003b1;-fucosidase activity</td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/tubb4a-leuk/">Hypomyelination w/atrophy of the basal ganglia &#x00026; cerebellum</a> (H-ABC)</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Likely AD</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TUBB4A</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical &#x00026; neuroradiologic features</td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/hypo-mcc/">Hypomyelination and congenital cataract</a> (HCC)</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FAM126A</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/krabbe/">Krabbe disease</a></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GALC</i><br />See footnote 4</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In leukocytes or fibroblasts: deficient galactocerebrosidase activity</td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">L-2-hydroxyglutaric aciduria</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>L2HGDH</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In plasma, urine, CSF: &#x02191;&#x000a0;concentration of L-2-hydroxyglutaric acid (and lysine)</td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/lbsl/">Leukoencephalopathy w/brain stem &#x00026; spinal cord involvement &#x00026; lactate elevation</a> (LBSL)</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>DARS2</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Leukoencephalopathy w/thalamus and brain stem involvement &#x00026; lactate elevation (LTBL)</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EARS2</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mlc/">Megalencephalic leukodystrophy w/subcortical cysts</a> (MLC)</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MLC1</i><br /><i>HEPACAM (MLC2)</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/mld/">Metachromatic leukodystrophy</a> (MLD)</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ARSA</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In leukocytes, fibroblasts: &#x02193;&#x000a0;arylsulfatase A activity;<br />In urine: &#x02191;&#x000a0;sulfatides</td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PSAP</i>-related MLD&#x000a0;<sup>5</sup></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PSAP</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In leukocytes, fibroblasts: normal arylsulfatase A activity;<br />In urine: &#x02191;&#x000a0;sulfatides</td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/m-sulfatase-def/">Multiple sulfatase deficiency</a> (MSD)</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SUMF1</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02193;&#x000a0;activity of other sulfatases;<br />In urine: &#x02191;&#x000a0;mucopolisaccharides, &#x02191;&#x000a0;urinary sulfatides</td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/hdls/">Hereditary diffuse leukoencephalopathy w/spheroids</a> (HDLS)&#x000a0;<sup>6</sup></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>CSF1R</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Oculodentodigital dysplasia (ODDD)</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Usually AD; may be AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GJA1</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pmd/">Pelizaeus-Merzbacher disease</a> (PMD)</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLP1</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pmld1/">Pelizaeus-Merzbacher-like disease 1</a> (PMLD1)</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GJC2</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pbd/">Zellweger spectrum disorder</a> (PBD, ZSD)&#x000a0;<sup>7</sup></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PEX</i> genes</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Plasma VLCFA, phytanic &#x00026; pristanic acid, plasma &#x00026; urine concentration of pipecolic acid &#x00026; bile acids aid to distinguish different forms of peroxisomal disorders</td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/pol3-leuk/">Pol III-related leukodystrophies</a>&#x000a0;<sup>8</sup></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>POLR3A</i><br /><i>POLR3B</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">RNAse T2-deficient leukoencephalopathy</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>RNASET2</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">Single-enzyme deficiencies of peroxisomal fatty acid beta oxidation&#x000a0;<sup>9</sup></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dibifunctional protein deficiency: <i>HSD17B4</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">Plasma VLCFA, phytanic &#x00026; pristanic acid, plasma &#x00026; urine concentration of pipecolic acid &#x00026; bile acids aid to distinguish different forms of peroxisomal disorders</td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">Peroxisomal acyl-CoA-oxidase deficiency: <i>ACOX1</i></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;">SCPx deficiency: <i>SCP2</i></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sj&#x000f6;gren-Larsson syndrome</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ALDH3A2</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In urine: abnormal metabolites of leukotriene B4;<br />In cultured skin fibroblasts, leukocytes: deficiency of fatty aldehyde dehydrogenase activity (FALDH) and/or of fatty alcohol:NAD oxidoreductase (FAO)</td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SOX10</i>-associated disorders</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SOX10</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/x-ald/">X-linked adrenoleukodystrophy</a> (X-ALD)</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ABCD1</i></td><td headers="hd_h_leukodys-ov.T.leukodystrophies_meeting_s_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">On plasma VLCFA assay: C26:0, &#x02191;&#x000a0;ratio of C24:0 to C22:0, &#x02191;&#x000a0;ratio of C26:0 to C22:0</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; VLCFA = very long-chain fatty acid; XL = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a></p></div></dd><dt></dt><dd><div><p class="no_margin">Disorders listed in alphabetic order; naming as per <i>GeneReviews</i></p></div></dd><dt>1. </dt><dd><div id="leukodys-ov.TF.1.1"><p class="no_margin">Genetic testing is available for many of these genes.</p></div></dd><dt>2. </dt><dd><div id="leukodys-ov.TF.1.2"><p class="no_margin">This disorder now appears to be distinct from Coats plus caused by pathogenic variants in <i>CTC1</i>, encoding conserved telomere maintenance component 1.</p></div></dd><dt>3. </dt><dd><div id="leukodys-ov.TF.1.3"><p class="no_margin">Includes Salla disease; infantile sialic acid storage disease, intermediate form</p></div></dd><dt>4. </dt><dd><div id="leukodys-ov.TF.1.4"><p class="no_margin">Defects in <i>PSAP</i> causing a deficiency in the activator protein of SapA-d essential for the action of GALC have been reported.</p></div></dd><dt>5. </dt><dd><div id="leukodys-ov.TF.1.5"><p class="no_margin">Pathogenic variants in <i>PSAP</i> result in deficiency in SapB-d, an activator protein essential for ARSA activity.</p></div></dd><dt>6. </dt><dd><div id="leukodys-ov.TF.1.6"><p class="no_margin">Also known as adult-onset leukodystrophy w/ neuroaxonal spheroids &#x00026; pigmented glia; may include hereditary diffuse; pigmentary type of orthochromatic leukodystrophy w/pigmented glia (POLD)</p></div></dd><dt>7. </dt><dd><div id="leukodys-ov.TF.1.7"><p class="no_margin">Includes neonatal adrenoleukodystrophy; infantile Refsum disease</p></div></dd><dt>8. </dt><dd><div id="leukodys-ov.TF.1.8"><p class="no_margin">Includes hypomyelination, hypodontia, hypogonadotropic hypogonadism (4H syndrome); ataxia, delayed dentition, and hypomyelination (ADDH); tremor-ataxia with central hypomyelination (TACH); leukodystrophy with oligodontia (LO); and hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC).</p></div></dd><dt>9. </dt><dd><div id="leukodys-ov.TF.1.9"><p class="no_margin">Includes D-bifunctional protein (DBP) deficiency; sterol <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> protein-2 (SCPx) deficiency; peroxisomal acyl-CoA-oxidase deficiency</p></div></dd></dl></div></div></div></div></div><div id="leukodys-ov.Genetic_Counseling"><h2 id="_leukodys-ov_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="leukodys-ov.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Leukodystrophies with an identified genetic cause may be inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner, an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> manner, or an <a class="def" href="/books/n/gene/glossary/def-item/x-linked-recessive/">X-linked recessive</a> manner; other inheritance patterns may be identified as more genetic causes of leukodystrophy are discovered.</p><p>If a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a specific syndrome associated with a leukodystrophy, counseling for that condition is indicated.</p></div><div id="leukodys-ov.Risk_to_Family_Members"><h3>Risk to Family Members</h3><div id="leukodys-ov.Autosomal_Dominant_Inheritan"><h4>Autosomal Dominant Inheritance</h4><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed as having <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> leukodystrophy have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent, although occasionally the family history is negative.</div></li><li class="half_rhythm"><div>Family history may appear to be negative because of early death of a parent, failure to recognize <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> leukodystrophy in family members, late onset in a parent, reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of the mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> in an asymptomatic parent, or a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to sibs depends on the genetic status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents.</div></li><li class="half_rhythm"><div>If one of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents has a mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, the risk to the sibs of inheriting the mutated allele is 50%.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Individuals with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> leukodystrophy have a 50% chance of transmitting the mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> to each child.</p></div><div id="leukodys-ov.Autosomal_Recessive_Inherita"><h4>Autosomal Recessive Inheritance</h4><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The parents are obligate heterozygotes and therefore carry a single copy of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Heterozygotes are asymptomatic.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>At conception, each sib of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a 25% chance of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, a 50% chance of being an asymptomatic <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>, and a 25% chance of being unaffected and not a carrier.</div></li><li class="half_rhythm"><div>Once an at-risk sib is known to be unaffected, the chance of his/her being a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> is 2/3.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> All offspring are obligate carriers.</p></div><div id="leukodys-ov.XLinked_Inheritance"><h4>X-Linked Inheritance</h4><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disease nor will he be a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Women who have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> son and another affected male relative are obligate heterozygotes. These females may be affected, sometimes with only certain features of the disease, or with milder symptoms. Note: If a woman has more than one affected child and no other affected relatives and if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. Rarely, the unaffected father of an affected female may have germline mosaicism.</div></li><li class="half_rhythm"><div>A mother of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> female who has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> may have favorably skewed <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> that results in her being unaffected or mildly affected.</div></li><li class="half_rhythm"><div>An individual who is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case) may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sib depends on the <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status of the mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Male sibs who inherit the variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; female sibs who inherit the variant will be carriers and will usually not be affected.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the risk to sibs is low but greater than that of the general population because of the possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Daughters of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will be obligate carriers and may or may not be affected; none of his sons will be affected.</div></li><li class="half_rhythm"><div>Each child of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> female has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Because of possible skewing of <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>, variable phenotypes in females are possible.</div></li></ul><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the genetic status of the proband's parents.</p></div></div><div id="leukodys-ov.Related_Genetic_Counseling_I"><h3>Related Genetic Counseling Issues</h3><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="leukodys-ov.Prenatal_Testing_and_Preimpl"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>(s) have been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for leukodystrophy are possible.</p></div></div><div id="leukodys-ov.Resources"><h2 id="_leukodys-ov_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Medical Home Portal</b></div><div><i>The Parents &#x00026; Families section of the Medical Home Portal provides information and resources to help families learn how to better care for a child with chronic and complex conditions and to become more effective partners in their child&#x02019;s care.</i></div><div>Department of Pediatrics University of Utah</div><div>P.O. Box 581289</div><div>Salt Lake City UT 84158</div><div><b>Phone:</b> 801-213-3920</div><div><b>Email:</b> info@medicalhomeportal.org</div><div><a href="https://www.medicalhomeportal.org/living-with-child" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">For Parents &#x00026; Families</a></div></li><li class="half_rhythm"><div><b>Myelin Disorders Bioregistry Project</b></div><div><b>Email:</b> myelindisorders@cnmc.org</div><div><a href="https://www.chop.edu/research/myelin-disorders-biorepository-project" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Myelin Disorders Bioregistry Project</a></div></li></ul></div><div id="leukodys-ov.Management"><h2 id="_leukodys-ov_Management_">Management</h2><div id="leukodys-ov.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Although the underlying mechanisms of leukodystrophies are diverse, many manifestations are similar across this group of disorders. In the great majority of cases, primary treatment is not possible, but management of symptoms can improve the comfort and care of individuals with these complex disorders.</p><p>Ideally, the child or adult with a leukodystrophy is managed in a multidisciplinary setting by providers experienced in the care of persons with a leukodystrophy.</p><p><b>Spasticity.</b> Pharmacologic agents are used to manage muscle tone and block neuronal signaling to muscle (chemodenervaton). Intensive physical therapy is used to improve mobility and function.</p><p><b>Extrapyramidal manifestations.</b> Dystonia and dyskinesias may cause significant disability; pharmacologic treatment may result in significant functional improvement.</p><p><b>Ataxia.</b> No specific treatment of ataxia exists, although rehabilitative measures can be of great assistance.</p><p><b>Seizures.</b> Seizures should be treated with typical anticonvulsants and are rarely refractory, except on occasion at the end of life.</p><p><b>Cognitive developmental delay / encephalopathy.</b> It is important to advocate for persons with a leukodystrophy in school or at work to avoid limitations related to their motor disabilities. Augmentative communication may be used to address speech deficits. Accommodations for cognitive delays and fine motor disabilities should be used as needed.</p><p><b>Orthopedic.</b> Attention should be given to the prevention and treatment of orthopedic problems, such as hip dislocation and scoliosis.</p><p><b>Feeding.</b> Swallowing dysfunction and pulmonary problems resulting from the increased risk of aspiration are common as the disease progresses. Decreased nutritional intake and failure to thrive may also occur. The decision to place a gastrostomy tube for nutrition is based on the overall health status of the individual, expected disease course, and family and patient wishes.</p></div><div id="leukodys-ov.Prevention_of_Primary_Manife"><h3>Prevention of Primary Manifestations</h3><p>Primary disease manifestations can be prevented in a few of the leukodystrophies: in <a href="/books/n/gene/x-ald/">X-linked adrenoleukodystrophy</a>, <a href="/books/n/gene/krabbe/">Krabbe disease</a>, and <a href="/books/n/gene/mld/">metachromatic leukodystrophy</a>, for example, hematopoietic stem cell transplantation (HSCT) or bone marrow transplantation (BMT) may be beneficial if performed early in the disease course. Patients with these disorders should be referred to specialized centers for consideration of HSCT or BMT [<a class="bk_pop" href="#leukodys-ov.REF.eichler.2009.1893">Eichler et al 2009</a>].</p></div><div id="leukodys-ov.Surveillance"><h3>Surveillance</h3><p>Standard surveillance includes the following:</p><ul><li class="half_rhythm"><div>Routine measurement of weight and height to assess growth and nutritional status</div></li><li class="half_rhythm"><div>Physical examination and/or serial x-rays of the hips and spine to monitor for orthopedic complications</div></li><li class="half_rhythm"><div>Routine history regarding signs and symptoms of seizures</div></li></ul><p>Certain disorders require specialized surveillance; for example, monitoring for the development of hydrocephalus in <a href="/books/n/gene/alexander/">Alexander disease</a>.</p></div><div id="leukodys-ov.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>In a number of leukodystrophies anecdotal evidence suggests episodic worsening of manifestations with mild head injuries and infection. While this has been clearly documented only for <a href="/books/n/gene/cach/">childhood ataxia with central nervous system hypomyelination/vanishing white matter</a>, it appears prudent to avoid these triggers when possible.</p></div><div id="leukodys-ov.Evaluation_of_Relatives_at_R"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#leukodys-ov.Genetic_Counseling">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="leukodys-ov.Therapies_Under_Investigatio"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="leukodys-ov.References"><h2 id="_leukodys-ov_References_">References</h2><div id="leukodys-ov.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="leukodys-ov.REF.bezman.2001.512">Bezman L, Moser AB, Raymond GV, Rinaldo P, Watkins PA, Smith KD, Kass NE, Moser HW. Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. <span><span class="ref-journal">Ann Neurol. </span>2001;<span class="ref-vol">49</span>:512–7.</span> [<a href="/pubmed/11310629" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11310629</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leukodys-ov.REF.bonkowsky.2010.718">Bonkowsky JL, Nelson C, Kingston JL, Filloux FM, Mundorff MB, Srivastava R. The burden of inherited leukodystrophies in children. <span><span class="ref-journal">Neurology. </span>2010;<span class="ref-vol">75</span>:718–25.</span> [<a href="/pmc/articles/PMC2931652/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2931652</span></a>] [<a href="/pubmed/20660364" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20660364</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leukodys-ov.REF.eichler.2009.1893">Eichler F, Grodd W, Grant E, Sessa M, Biffi A, Bley A, Kohlschuetter A, Loes DJ, Kraegeloh-Mann I. Metachromatic leukodystrophy: a scoring system for brain MR imaging observations. <span><span class="ref-journal">AJNR Am J Neuroradiol. </span>2009;<span class="ref-vol">30</span>:1893–7.</span> [<a href="/pubmed/19797797" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19797797</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leukodys-ov.REF.heim.1997.475">Heim P, Claussen M, Hoffmann B, Conzelmann E, G&#x000e4;rtner J, Harzer K, Hunneman DH, K&#x000f6;hler W, Kurlemann G, Kohlsch&#x000fc;tter A. Leukodystrophy incidence in Germany. <span><span class="ref-journal">Am J Med Genet. </span>1997;<span class="ref-vol">71</span>:475–8.</span> [<a href="/pubmed/9286459" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9286459</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leukodys-ov.REF.schiffmann.2009.750">Schiffmann R, van der Knaap MS. Invited article: an MRI-based approach to the diagnosis of white matter disorders. <span><span class="ref-journal">Neurology. </span>2009;<span class="ref-vol">72</span>:750–9.</span> [<a href="/pmc/articles/PMC2677542/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2677542</span></a>] [<a href="/pubmed/19237705" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19237705</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leukodys-ov.REF.van_der_knaap.1999.121">van der Knaap MS, Breiter SN, Naidu S, Hart AA, Valk J. Defining and categorizing leukoencephalopathies of unknown origin: MR imaging approach. <span><span class="ref-journal">Radiology. </span>1999;<span class="ref-vol">213</span>:121–33.</span> [<a href="/pubmed/10540652" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10540652</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="leukodys-ov.REF.van_der_knaap.2005">van der Knaap MS, Valk J. <em>Magnetic Resonance of Myelination and Myelin Disorders</em>. Berlin, Germany: Springer. 2005.</div></li></ul></div></div><div id="leukodys-ov.Chapter_Notes"><h2 id="_leukodys-ov_Chapter_Notes_">Chapter Notes</h2><div id="leukodys-ov.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>6 February 2014 (me) Review posted live</div></li><li class="half_rhythm"><div>14 February 2012 (av) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK184570</span><span class="label">PMID: <a href="/pubmed/24501781" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">24501781</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/lns/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/lbsl/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK184570&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK184570/?report=reader">PubReader</a></li><li><a href="/books/NBK184570/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK184570" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK184570" style="display:none" title="Cite this Page"><div class="bk_tt">Vanderver A, Tonduti D, Schiffmann R, et al. Leukodystrophy Overview. 2014 Feb 6. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK184570/pdf/Bookshelf_NBK184570.pdf">PDF version of this page</a> (1.7M)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#leukodys-ov.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#leukodys-ov.Definition_of_Leukodystrophy" ref="log$=inpage&amp;link_id=inpage">Definition of Leukodystrophy</a></li><li><a href="#leukodys-ov.Clinical_Manifestations_of_L" ref="log$=inpage&amp;link_id=inpage">Clinical Manifestations of Leukodystrophies</a></li><li><a href="#leukodys-ov.Prevalence_of_Leukodystrophi" ref="log$=inpage&amp;link_id=inpage">Prevalence of Leukodystrophies</a></li><li><a href="#leukodys-ov.Differential_Diagnosis_of_Le" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis of Leukodystrophies</a></li><li><a href="#leukodys-ov.Evaluation_Strategy_for_an_I" ref="log$=inpage&amp;link_id=inpage">Evaluation Strategy for an Individual with a Leukodystrophy</a></li><li><a href="#leukodys-ov.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#leukodys-ov.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#leukodys-ov.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#leukodys-ov.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#leukodys-ov.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=3071542" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=3071542" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301621" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Zellweger Spectrum Disorder</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Zellweger Spectrum Disorder<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Steinberg SJ, Raymond GV, Braverman NE, Moser AB. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301334" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Dystonia Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Dystonia Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Klein C, Lohmann K, Marras C, Münchau A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301435" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Childhood Ataxia with Central Nervous System Hypomyelination / Vanishing White Matter<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">van der Knaap MS, Fogli A, Boespflug-Tanguy O, Abbink TEM, Schiffmann R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301317" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Ataxia Overview</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hereditary Ataxia Overview<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bird TD. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301648" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Aicardi-Goutières Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Aicardi-Goutières Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Crow YJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=24501781" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=24501781" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040d9839a66ee2ba5e2e2e">Leukodystrophy Overview - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Leukodystrophy Overview - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:32:08-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal102&amp;ncbi_phid=CE89C50AE04057810000000003DB01AF&amp;ncbi_session=CE89C50AE040D971_0987SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK184570%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK184570&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK184570/&amp;ncbi_pagename=Leukodystrophy Overview - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE89C50AE040D971_0987SID /projects/books/PBooks@5.22 portal102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>